Literature DB >> 16175440

A rare cause of myocardial infarction: acute inferoposterior myocardial infarction after successful intravenous thrombolytic treatment of mechanical mitral prosthetic valve thrombosis.

Ahmet Altinbas1, Zehra Kucuktepe, Mehmet Ozaydin, Suleyman Murat Aslan, Mehmet Demir, Emine Altinbas.   

Abstract

Prosthetic valve thrombosis is a rare and dreaded complication of patients with mechanical valves, particularly those in the mitral position. A 45-year-old female with status post prosthetic mitral valve replacement was admitted to the hospital with acute pulmonary edema. Echocardiography showed mitral valve thrombosis which was treated with tissue plasminogen activator (t-PA). During t-PA infusion she developed acute inferoposterior myocardial infarction. Coronary angiography showed normal coronary arteries. Presented case had acute inferoposterior myocardial infarction secondary to coronary emboli after the successful thrombolytic treatment of prosthetic mitral valve thrombosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175440     DOI: 10.1007/s10554-004-8331-1

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  4 in total

Review 1.  Prosthetic valve thrombosis and thrombolysis: a case report and review of the literature.

Authors:  N Tsiouris; M Ahmad
Journal:  Am J Med Sci       Date:  2001-10       Impact factor: 2.378

Review 2.  ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).

Authors: 
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

Review 3.  Management of prosthetic valve thrombosis.

Authors:  Maria Lengyel
Journal:  J Heart Valve Dis       Date:  2004-05

4.  Prosthetic valve thrombosis-case report and literature review.

Authors:  Abdulhalim Jamaluddeen Kinsara; Saad Al-Bogami
Journal:  Eur J Intern Med       Date:  2003-11       Impact factor: 4.487

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.